SPY382.33-9.44 -2.41%
DIA313.98-5.55 -1.74%
IXIC13,119.43-478.54 -3.52%

--Analyst Actions: RBC Capital Adjusts Neurocrine Biosciences' Price Target to $124 From $117, Maintains Outperform Rating

· 02/05/2021 03:34

08:29 AM EST, 02/05/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 112.00, Change: -2.55, Percent Change: -2.23